Unit 6 - Rx of the CNS Flashcards
Continuum Chart
- death
- convulsion or seizures
- tremors and hallucinations
- anxiety
- euphoria
- NORMAL– neutral
- sedation (drowsy)
- hypnosis (sleep)
- general anesthesia
- coma
- death
stimulation increases:
- sensory acuity
- motor activity
depression inhibits:
- sensory acuity
- motor activity
CNS stimulants
MOA: increase excitability of CNS increases lvls of nor-epi in brain.
Agents:
- Amphetamines
- Xanthines
- Cocaine / cocaine derivatives
Amphetamines:
therapeutic uses for CNS stimulants
Amphetamines: narcolepsy, weight control (?), ADHD
Amphetamines:
side effects of CNS stimulants
- CNS: to much stimulation…nervousness, anxiety,
sleeplessness - Cardiovascular: too much nor-epi..increase adrenergic response. Increase HR, BP, potential arrhythmias.
- Weight loss, malnutrition
- Kids: suppression of growth
- Possible bone marrow suppression
therapeutic uses for CNS stimulants
Xanthines: pain from headache (vasoconstriction in brain), asthma, bronchitis, emphysema (bronchorelaxation), counter drowsiness
Cocaine derivates: local anesthetics
CNS depressants
Agent which decreases excitability of tissue in CNS
- Produces sedation, hypnosis, general anesthesia, coma, death
- All drugs in this category can be used as sedatives, hypnotics or general anesthetics…it is dose dependent.
- Higher the dose the greater the depression.
Sedative
drugs administered at a dose level to cause mild drowsiness or sedation or to reduce restlessness & anxiety.
Hypnotic
drugs which are administered at a dose lvl to induce sleep or allow an individual to stay asleep. (they can be awoken from this sleep)
General Anesthetic
a drug given at a dose to depress the CNS to a degree that causes a loss of consciousness (unarousable), as well as analgesia.
Sedative Hypnotic
- Oldest, largest and most studied class of CNS drugs
- Produce varying degrees of CNS depression depending on the dose administered
- Produce generalized depression of the cellular activity of many organ systems as well as the tissue w/in CNS
- Synapse is the site of action.
Drug classes: barbiturates
Barbiturates and Benzodiazepines
MOA: act at gabba receptor / chloride ion channel complex
- Both barbiturates and benzos act on these complexes.
- bind diff allosteric sites
- Gabba is an inhibitory neurotransmitter and will produce inhibitory postsynaptic potentials
- Chloride flows through the channel and decreases resting membrane potential.
- Neuron, therefore, is less likely to be stimulated
Benzos: _____ dependent
gabba
Therapeutic Uses: Sedative Hypnotics
- relieves anxiety
- sleep disorders
- epilepsy (barbiturates)
Side effects: Sedative Hypnotics
- Drowsiness
- Impaired performance or decreased perception
and judgment
- Hangover effect
- Hyperalgesia (barbiturates only)
- Overdose - resp. depression (barbiturates, but can be true of any depressants in combination)
Cautions: Sedative Hypnotics
- Additive w/ other sedative-hypnotics
- Drug abuse and habituation
- W/drawal state: most severe possible
- Sx can last up to 6 wks+
General anesthetics
Goals:
- Analgesia (narcotics, Ketamine)
- Loss of consciousness (gases, nitrous oxide)
- Muscle relaxation (maybe curare)
Types
General anesthetics
- inhalation
- IV
Antiepileptic Agents
MOA: 2 ways
- Decreasing movement of ions into nerve cells (block Na) and therefore, reduce repetitive firing of neurons.
- Phenytoin, oxycarbazine - Alters activity of neurotransmitter
(increasing GABA or decrease glutamate)
- Benzos (clonazepam), Barbiturates (phenobarbital), newer AED’s
Antiepileptic Agents:
Goal of treatment
- Control the seizures w/o significant CNS impairment.
Frequent adverse effects:
- Sedation - locomotor and CNS
- Kidney, liver damage
- Blood diseases
- Each agent has it’s own adverse effects
Parkinson’s Disease
loss of dopaminergic neurons resulting in an imbalance of dopamine and acetylcholine in the basal ganglia (substancia nigra)
Parkinson’s Disease - treatment
- increase dopamine
- decrease acetylcholine
Antiparkinsonian Agents
- Leva-dopa
- Bromocriptine
- Selegiline
- Anticholinergic drugs